
Pharmaceutical companies should be allowed to continue testing experimental painkiller drugs for osteoarthritis according to a recommendation of an advisory panel for the US Food and Drug Administration.
The panel recommended unanimously that the FDA should revoke its ban on companies such as Pfizer and Regeneron Pharmaceuticals and allow them to continue their clinical trials of the drugs.
The health regulator had suspended the testing on the drugs back in 2010 after finding that they destroyed the joints with nearly 500 participants in the clinical trials requiring joints replacements.
Source: Medindia